BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
1-Year Return
13.74%
This Quarter Return
+1.01%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$2.07B
AUM Growth
+$547M
(+36%)
Cap. Flow
+$411M
Cap. Flow
% of AUM
19.83%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
1,468
New
461
Increased
291
Reduced
285
Closed
388
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$98M |
| 2 |
Microsoft
MSFT
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$79.5M |
| 4 |
Spotify
SPOT
|
+$30.1M |
| 5 |
Eli Lilly
LLY
|
+$26.8M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$57.9M |
| 2 |
Apple
AAPL
|
+$50.2M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$31.9M |
| 4 |
UnitedHealth
UNH
|
+$22.1M |
| 5 |
Super Micro Computer
SMCI
|
+$20.5M |
Sector Composition
| 1 | Technology | 17.44% |
| 2 | Financials | 14.17% |
| 3 | Healthcare | 10.68% |
| 4 | Industrials | 10.29% |
| 5 | Communication Services | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
John B. Sanfilippo & Son
JBSS
$729M
| $270K | ﹤0.01% |
+2,860
| New | +$270K |
|
827
Guardant Health
GH
$7.21B
| $270K | ﹤0.01% |
+11,757
| New | +$270K |
|
828
Westlake Corp
WLK
$11.2B
| $269K | ﹤0.01% |
1,793
-5,227
| -74% | -$786K |
|
|
INN
829
Summit Hotel Properties
INN
$619M
| $269K | ﹤0.01% |
39,281
+22,014
| +127% | +$151K |
|
830
BJ's Restaurants
BJRI
$695M
| $269K | ﹤0.01% |
+8,262
| New | +$269K |
|
831
International Seaways
INSW
$2.28B
| $269K | ﹤0.01% |
+5,214
| New | +$269K |
|
832
Cheesecake Factory
CAKE
$2.89B
| $269K | ﹤0.01% |
6,629
-1,326
| -17% | -$53.8K |
|
833
Virtus Investment Partners
VRTS
$1.33B
| $269K | ﹤0.01% |
1,282
-1,441
| -53% | -$302K |
|
834
US Physical Therapy
USPH
$1.24B
| $266K | ﹤0.01% |
+3,144
| New | +$266K |
|
835
BrightSpring Health Services
BTSG
$4.97B
| $265K | ﹤0.01% |
+18,041
| New | +$265K |
|
|
RDUS
836
DELISTED
Radius Recycling
RDUS
| $265K | ﹤0.01% |
+14,283
| New | +$265K |
|
837
Avidity Biosciences
RNA
$4.7B
| $263K | ﹤0.01% |
+5,728
| New | +$263K |
|
838
Warby Parker
WRBY
$3.33B
| $262K | ﹤0.01% |
16,044
-18,607
| -54% | -$304K |
|
839
TriCo Bancshares
TCBK
$1.48B
| $261K | ﹤0.01% |
+6,130
| New | +$261K |
|
840
Healthpeak Properties
DOC
$12.5B
| $261K | ﹤0.01% |
+11,415
| New | +$261K |
|
841
BlueLinx
BXC
$642M
| $260K | ﹤0.01% |
2,466
-618
| -20% | -$65.2K |
|
842
California Water Service
CWT
$2.72B
| $259K | ﹤0.01% |
4,785
-5,530
| -54% | -$300K |
|
843
Sylvamo
SLVM
$1.76B
| $259K | ﹤0.01% |
3,017
-4,944
| -62% | -$424K |
|
844
Option Care Health
OPCH
$4.76B
| $259K | ﹤0.01% |
8,271
-10,257
| -55% | -$321K |
|
845
Carnival Corp
CCL
$43.5B
| $259K | ﹤0.01% |
+14,006
| New | +$259K |
|
846
Integra LifeSciences
IART
$1.22B
| $259K | ﹤0.01% |
+14,232
| New | +$259K |
|
847
UWM Holdings
UWMC
$1.52B
| $258K | ﹤0.01% |
30,253
+5,807
| +24% | +$49.5K |
|
848
Koppers
KOP
$548M
| $257K | ﹤0.01% |
+7,041
| New | +$257K |
|
849
Liberty Latin America Class C
LILAK
$1.54B
| $256K | ﹤0.01% |
26,988
+6,966
| +35% | +$66.1K |
|
850
Universal Corp
UVV
$1.38B
| $256K | ﹤0.01% |
+4,812
| New | +$256K |
|